Erlocip 150mg Tablet contains Erlotinib, a targeted cancer therapy classified as a tyrosine kinase inhibitor (TKI). It is primarily used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlocip works by blocking the action of epidermal growth factor receptor (EGFR), which plays a key role in the growth and spread of cancer cells.

Uses of Erlocip 150mg Tablet

• Non-Small Cell Lung Cancer (NSCLC): Used in patients with EGFR-positive NSCLC, either as a first-line therapy or in cases where previous treatments have not been effective.
• Pancreatic Cancer: Administered in combination with chemotherapy (Gemcitabine) to slow cancer progression.

How Erlocip 150mg Works

Erlotinib, the active ingredient in Erlocip, inhibits epidermal growth factor receptor (EGFR)-tyrosine kinase, a protein involved in cancer cell growth and survival. By blocking this protein, the drug prevents cancer cells from multiplying and spreading, effectively slowing down tumor progression.

Dosage & Administration

• The recommended dose is 150mg once daily, at least 1 hour before or 2 hours after a meal.
• The dose may be adjusted based on a doctor’s evaluation of side effects and response to treatment.

If a dose is missed, it should be taken as soon as possible unless it is close to the next dose.

Precautions & Warnings

Who Should Avoid Erlocip?

• Patients with severe liver or kidney disease
• Individuals with lung disease (other than cancer)
• People allergic to Erlotinib or similar medications

Possible Side Effects

• Common: Rash, diarrhea, nausea, vomiting, fatigue, dry skin, loss of appetite
• Less Common: Eye irritation, cough, difficulty breathing, mouth sores
• Serious (Seek Medical Help): Severe lung inflammation, liver dysfunction, gastrointestinal perforation, severe skin reactions

If any severe side effects occur, immediate medical attention is necessary.

Drug Interactions

Certain medications and foods can affect how Erlocip 150mg works.

Avoid taking Erlocip with:

• Proton Pump Inhibitors (PPIs) (e.g., Omeprazole, Pantoprazole) – May reduce drug effectiveness.
• Strong CYP3A4 inducers (e.g., Rifampicin, Phenytoin) – Can lower Erlocip levels in the blood.
• Grapefruit or Grapefruit Juice – May increase the risk of side effects.
• Blood thinners, like Warfarin, can make bleeding more likely.

Discuss all medications and supplements with your doctor before starting Erlocip.

Storage Instructions

• Store in a cool, dry place at room temperature (20-25°C).
• Keep away from moisture and direct sunlight.
• Store out of reach of children and pets.

Frequently Asked Questions (FAQs)

1. Can Erlocip 150mg cure cancer?

Erlocip is not a cure for cancer, but it helps slow the growth and spread of cancer cells, improving survival rates and quality of life.

2. How long should I take Erlocip 150mg?

The duration of treatment depends on cancer type, response to therapy, and side effects. Treatment should continue as long as the doctor recommends.

3. Can I take Erlocip with food?

No, Erlocip should be taken on an empty stomach (1 hour before or 2 hours after a meal) for better absorption.

4. What should I do if I experience severe diarrhea?

Drink plenty of fluids and consult your doctor immediately. In some cases, anti-diarrheal medications may be needed.

5. Can Erlocip cause skin problems?

Yes, a rash is a common side effect and may indicate that the drug is working. However, severe skin reactions should be reported to a doctor.

6. Is Erlocip safe for elderly patients?

Yes, but older adults may be more sensitive to side effects. Regular monitoring is required.

7. Can pregnant or breastfeeding women take Erlocip?

No, Erlocip can harm the unborn baby. Effective contraception should be used during treatment, and breastfeeding should be avoided.

8. What should I avoid while taking Erlocip?

Avoid smoking, alcohol, grapefruit, and excessive sun exposure, as these can reduce the drug’s effectiveness or increase side effects.

9. Can I take other cancer treatments along with Erlocip?

Your doctor will determine if Erlocip can be combined with other treatments based on your specific cancer type and condition.

10. Will I lose my hair while taking Erlocip?

Erlocip does not usually cause hair loss, but some patients may experience thinning or brittle hair.